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Abstract
Background: The root bark of Zizyphus nummularia (Rhamnaceae) is traditionally used as an anti-inflammatory
agent. The current study aimed to explore the anti-inflammatory activity (in vivo) of a crude ethanolic extract (EE)
and the pure identified octadecahydro-picene-2,3,14,15-tetranone (IC) in the root bark of Z. nummularia. IC was
further subjected to suitable in vitro and in silico studies to find out the mechanistic pharmacology.
Methods: EE (100 and 200 mg/kg, p.o.) and (IC) (400 and 600 μg/kg, p.o.) were subjected to in vivo anti-inflammatory
assays to evaluate the anti-inflammatory activity and predict the probable mechanism(s) of action. Suitable
acute (carrageenan-induced paw edema, arachidonic acid-induced ear edema, xylene-induced ear edema) and
chronic (cotton pellet granuloma) models were employed to investigate in vivo the anti-inflammatory activity.
Based on in vivo observation, IC was further subjected to in vitro assays to estimate the inhibition of nitric
oxide (NO), prostaglandin-E2 (PGE-2) and tumor necrosis factor-α (TNF-α) production in PBS stimulated RAW
264.7 cells. Based on the observation of in vitro studies, finally, ADME prediction and molecular docking
studies of IC were performed for better understanding of interaction of IC with TNF-α.
Results: Oral administration of EE (100 and 200 mg/kg) exhibited significant inhibition of carrageenan (p < 0.05) and
arachidonic acid (p < 0.05) induced oedema, and the reduced the granuloma tissue formation (p < 0.05) in
experimental mice. IC (400 and 600 μg/kg, p.o.) exhibited significant (p < 0.01) inhibition of carrageenan,
xylene and arachidonic acid-induced edema, and reduced the granuloma tissue formation. In in vitro assays,
IC caused a concentration-dependent inhibition of LPS stimulated NO (up to ~ 67.4 % at 50 μM) and TNF-α
(~84.5 % at 50 μM) production. However, the PGE-2 inhibition did not follow dose dependent pattern. Based
on in vitro observations, the molecular docking has been performed on the basis of interaction with TNF-α.
In in silico studies, it was observed that IC showed hydrogen bonding with GLN 47 amino acid residue of
TNF-α protein.
Conclusions: IC possibly produces anti-inflammatory activity through inhibition of TNF-α and NO production.
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Background
Inflammation is the complex biological response to
pathophysiological events mediated by various signalling
molecules produced by leukocytes, macrophages and
mast cells [1]. During inflammation, enhanced vascular
permeability coupled with migration of blood corpuscles
into the inflammatory site/s causes oedema, erythema
and pain. Various inflammatory mediators, namely nitric
oxide (NO), prostaglandin-2 (PGE-2), interleukins (ILs)
and tumor necrosis factor (TNF-α) play an imperative
role during the progress of inflammation [2]. Inflamma-
tion is major cause of morbidity throughout the world [3].
If untreated, it may lead to various associated diseases like
arthritis, atherosclerosis, and even cancer [4–6]. Serious
adverse effects of most of commercially available anti-
inflammatory drugs largely encourage the development of
new, target specific and less toxic anti-inflammatory
agents from plants [7]. Many Indian herbs have been
claimed to exert notable anti-inflammatory activity with-
out producing considerable untoward effects [8, 9]. Re-
cently computer-aided drug design by in silico computer
aided drug design is being employed in rational drug dis-
covery to understand the inhibitor-receptor interactions
and predict the inhibitory activity of new compounds.
Therefore, the combination of ethnopharmacological lit-
erature and modern scientific tools including molecular
docking is now believed to offer a holistic approach of
novel drug discovery.
Zizyphus nummularia Aubrev. (Rhamnaceae), a thorny
small bush or shrub, grows in abundance in the grazing
lands of the arid and semi-arid regions of India. The
plant is used in traditional medicine as analgesic, anti-
inflammatory, antitussive, anthelmintic, and anti-cancer
drug [10–12]. Leaves and root bark of the plant are
used as the remedy of inflammation by the local com-
munities of eastern India. While, much work exists on
extracts of leaves in animal model proving the anti-
inflammatory action [13–16]. On other hand, there is
no literature on rationalization of anti-inflammatory ac-
tivity of root bark of Z. nummularia by experimental
models. However, the root barks of different species
under the same genus, Zizyphus, have been reported to
possess significant anti-inflammatory activity [17–19].
Considering the ethnopharmacological relevance and
the existing literatures in support of anti-inflammatory
activities of the root bark of Zizyphus species, the present
study was designed to rationalize the anti-inflammatory
activity of the crude extract and of the isolated compound,
octadecahydro-picene-2,3,14,15-tetranone, from the root
bark of Z. nummularia employing in vivo animal models.
The earlier reports regarding anti-inflammatory activity of
some small molecules bearing similar pentacyclic struc-
ture [20–22] encouraged us to pursue the study of anti-
inflammatory activity of this isolated compound. Based on
the observation of the in vivo bioassay, the mechanism of
action of the isolated compound was studied with respect
to in vitro assays in murine monocytic macrophage cell
line (RAW 264.7). Therefore, IC was further subjected to




Root bark of Z. nummularia was collected in September
2010 from Durgapur, India and authenticated (Ref.
CNH/I-I/20/2010/Tech.II/171) by Dr. V. P. Parsad,
Taxonomist, Central National Herbarium, Botanical Sur-
vey of India, Shibpur, India. A voucher specimen (BCRCP/
DP/PT/02/06) was deposited at Dr. B. C. Roy College of
Pharmacy & Allied Health Sciences, Durgapur, India for
future reference. The detailed methods of extraction, iso-
lation and structure elucidation have been described in
our previous publication [12]. The structure of IC has
been depicted in Fig. 1. EE and IC were suspended in
Tween-80 (1 %) prior to each animal experiment. For in
vitro assays, IC was solubilised in DMSO in a master plate
(resultant ≤ 0.4 % DMSO in contact to cells to avoid
DMSO induced cytotoxicity). Briefly, the IC solution of
different concentrations in 100 % DMSO in a master plate
was diluted (1 in 25 dilution resulting 4 % DMSO) in a
drug dilution plate. Finally, IC solution of desired concen-
trations was introduced into cells (1 in 10 dilution result-
ing 0.4 % DMSO).
Chemicals
Cell line RAW264.7 was obtained from SIGMA-RBI,
Switzerland. Dulbecco’s Modified Eagle Medium (DMEM),
phosphate buffered saline (PBS) and Griess reagent were
procured from Invitrogen, Carlsbad, USA. Lipopolysacchar-
ide (LPS), foetal bovine serum (FBS) from E. coli (serotype
Fig. 1 The structure of isolated picene compound, octadecahydro-
picene-2,3,14,15-tetraone
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0111:B4), dimethylsulfoxide (DMSO) and sodium nitrite
were procured from Sigma (St Louis, USA). All solvents
and reagents used were of analytical grade.
In vivo anti-inflammatory activity
Swiss albino mice (♂, 25 ± 5 g, age: 2–3 months) were
housed in standard polyprophylene cages (3 mice/cage)
under standard laboratory conditions of 12:12 light–dark
cycle, temperature (20 ± 2 °C), relative humidity (55 ± 5 %),
standard diet (Hindustan Liver Ltd. Mumbai, India) and
water ad libitum. The animal experiments were conducted
in accordance with the institutional animal ethical commit-
tee of Dr. B. C. Roy College of Pharmacy and AHS (Reg
No: BCRCP/IAEC/8/2012).
Carrageenan-induced paw oedema
Mice were divided into six groups (n = 6) and the acute
inflammation was induced by carrageenan [23]. Pedal in-
flammation was induced by a single subcutaneous injec-
tion of carrageenan (0.1 ml, 1 %, w/v, in normal saline)
into the right paw of each mouse under the subplantar
aponeurosis. Thirty minutes prior to carrageenan injec-
tion, the first group of mice received orally tween-80 (1 %)
and served as inflammation control. The second and third
group were treated orally with EE at the doses of 100 and
200 mg/kg, respectively, while, fourth and fifth groups
were treated with IC at the doses of 400 and 600 μg/kg,
respectively. A group of mice was treated with the stand-
ard anti-inflammatory drug, aspirin (positive control). The
paw volume was measured by dipping the foot in the
mercury bath of a plethysmometer up to the anatomical
hairline on lateral malleolus and compared with control
animals. The paw volumes were recorded at 0, 1, 2, 3, 4
and 5 h following carrageenan injection.
Arachidonic acid and xylene-induced right ear oedema
Inflammation was induced in mice (n = 6/group) by
applying on the inner and outer surfaces of the right
ear 30 μl of following irritants: arachidonic acid
0.1 mg/μl in acetone [24] and xylene [25]. Thirty mi-
nutes prior to irritants’ treatment, two groups of mice
received orally tween-80 (1 %) and served as control
group. The other groups were treated orally with EE
(100 and 200 mg/kg) and IC (400 and 600 μg/kg), re-
spectively. Two groups of mice were treated with the
standard anti-inflammatory, aspirin (10 mg/kg) (positive
Table 1 The Qikprop® properties and descriptors
Sl no. Descriptor Description Recommended range
1 mol_MW Molecular weight of the molecule 130.0–725.0
2 SASA Total solvent accessible surface area (SASA) in square angstroms using a probe with a
1.4 A0 radius
300.0–1000.0
3 FOSA Hydrophobic component of the SASA (saturated carbon and attached hydrogen) 0.0–750.0
4 FISA Hydrophilic component of the SASA (SASA on N, O and hydrogen on heteroatom) 7.0–330.0
5 PISA Π (carbon and attached hydrogen) component of SASA 0.0–450.0
6 Volume Total solvent-accessible volume in cubic angstroms using a probe with 1.4 A0 radius 500.0–2000.0
7 donorHB Estimated number of hydrogen bonds that would be donated by the solute to water
molecules in an aqueous solution. Values are averages taken over a number of configurations,
so they can be non-integer
0.0–6.0
8 accptHB Estimated number of hydrogen bonds that would be accepted by the solute to water
molecules in an aqueous solution. Values are averages taken over a number of configurations,
so they can be non-integer
2.0–20.0
9 QPlogP o/w Predicted octanol/water partition coefficient −2.0-6.5
10 Human oral
absorption
Predictive qualitative human oral absorption. The assessment uses a knowledge-based set
of rules, including checking for suitable values percent human oral absorption, number of
metabolites, number of rotatable bonds logP, solubility and cell permeability
1, 2, 3 for low, medium and
high absorption respectively
11 % human oral
absorption
It predicts human oral absorption on 0 to 100 % scale. The prediction is based on a
quantitative multiple linear regression model. This property usually correlates well with
human oral absorption.
>80 % is high <25 % is poor
12 #rtvFG This particular descriptor indicates the number of reactive functional groups. The presence
of these groups can lead to decomposition, reactivity, or toxicity problems in vivo.
0 to 2.0
13 CNS Predictive central nervous activity on a −2 (inactive) to +2 (active) scale. −2.0 to 2.0
14 Lipinski’s rule of
five
Lipinski’s rules of five are: mol_MW< 500, QPlogPo/w < 5, donorHB≤ 5, accptHB≤ 10.
Compounds that satisfy these rules are considered drug like. (The “five” refers to the limits,
which are multiples of 5).
Maximum is 4
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control). The left ear served as normal control. Thirty mi-
nutes after the arachidonic acid injection, the mice under
different groups were subjected to CO2 euthanasia and
sacrificed by cervical dislocation. Both ears were removed
and weighed. The data were represented as percent of
oedema weight.
Cotton pellet-induced granuloma
This study was carried out following the protocol of
Ismail and co-authors [26] with little modification.
Sterile cotton pellets (10 ± 0.5 mg) were implanted
subcutaneously on the backs of mice. The six groups
(n = 6/group) of mice were treated with aqueous
tween 80 (1 %), EE (100 and 200 mg/kg), IC (400
and 600 μg/kg) and aspirin (10 mg/kg) orally, once
daily over 7 consecutive days. On day 8, the mice
were subjected to CO2 euthanasia and sacrificed by
cervical dislocation. The cotton pellet were removed,
dried overnight at 60 °C and weighed.
In vitro anti-inflammatory activity of IC
Cell culture
The RAW 264.7 cells were maintained in DMEM sup-
plemented with FBS (10 %), glucose (4.5 g/l), sodium
pyruvate (1 mM), L-glutamine (2 mM), streptomycin
(50 μg/ml) and penicillin (50 U/ml) at 37 °C and 5 %
CO2. The medium was routinely changed on alternate
days. The cells were passaged by trypsinization (Trypsin-
EDTA) to disrupt cell monolayer at confluence while
splitting RAW264.7 cells for the routine culture and
plating the cells for the in vitro assays.
Cytotoxicity assay
The cytotoxic effect of IC was determined by cell viability
assay. Briefly, Cell suspension was seeded into a 96-well
plate (~4 × 105 cells/well) and incubated for 12 h (37 °C;
5 % CO2) to allow cell attachment. The cells were then
incubated with IC (1–1000 μM) at 37 °C and 5 % CO2
tension. The cell viability was assessed at 2 h and 4 h by
MTT assay [27]. IC did not cause any loss of cell viability
up to 100 μM as compared with untreated RAW264.7
cells (data were shown in Additional file 1: Figure S1).
Estimation of NO, PGE-2 and TNF-α inhibitory activity
Cell suspension was seeded into a 96-well plate (~4 × 105
cells/well) and incubated for 12 h (37 °C; 5 % CO2) to
Table 2 Top-ranked SiteMap® prediction for receptor binding sites
Sl. no Title Site score
1 Sitemap_site1 0.643
2 Sitemap_site2 0.566
Fig. 2 The centroid of the sitemap_site1 used in the generation of grid of TNF-α receptor. Hydrophobic map: yellow mesh; hydrogen bond
(HB) donor map: blue mesh; HB acceptor map: red mesh. White points indicate generated site points
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allow cell attachment. The cells were then stimulated with
lipopolysaccharide (1 μg/ml) and different concentrations
of IC. Nitrite accumulation, an indicator of NO synthesis,
was measured in culture media based on a diazotization
reaction using the Griess reagent [28]. The nitrite concen-
tration was measured using sodium nitrite as a standard.
PGE-2 and TNF-α in the supernatant were measured
using ELISA kits (eBioscience, USA) according to manu-
facturer’s instructions.
In silico ADME prediction and molecular docking studies
of IC
The pharmacokinetic profile of IC was assessed using ab-
sorption, distribution, metabolism, elimination (ADME)
prediction methods. The compound was subjected to
evaluation by the QikProp® (Version 3.2) module of the
Maestro Schrodinger (MS) software for prediction of
pharmacokinetic properties. IC was neutralized before be-
ing subjected to QikProp® analysis and significant pharma-
cokinetic properties consisting of principal descriptors
such as mol_MW, SASA, FOSA, FISA, PISA, volume,
donarHB, accptHB, QPlogPo/w, human oral absorption,
percent human oral absorption, #rtvFG, CNS activity and
finally Lipinski’s rule of five. The details of QikProp® prop-
erties and descriptors are listed in Table 1. The compli-
ance of the IC to the Lipinski’s rule of five holds the
potential for the molecule to be further developed in drug
design programmes.
Active site prediction and molecular docking
Preparation of the ligand
TNF-α inhibitory activity of IC in the in vitro assay was
taken in to consideration to study the mode of inhibition
of the selected TNF-α protein. The 3D structures of the
IC was built using Maestro 9.0 build panel and prepared
by LigPrep 2.3 version v23118 (Schrödinger, LLC., USA).
The application uses Optimized Potentials for Liquid
Simulations (OPLS) 2005 force field and energy mini-
mized with Macromodel-v97110.
Preparation of the protein and prediction of active site
A docking study was carried out at the receptor site of
TNF-α protein to find out the putative binding mode of
the isolated compounds. The crystal structure of recom-
binant human TNF-α with a resolution of 2.30 Å was
retrieved from the protein data bank (PDB ID: 1A8M)
[29]. The structure was prepared by the protein prepar-
ation wizard within the Maestro Schrödinger®9.0 mod-
ule, which was further utilized to predict the possible
active site. As the selected TNF-α protein was devoid of
associated co-crystallized ligand, therefore the location
of the primary binding site on a receptor was unknown.
Fig. 3 The centroid of the sitemap_site1 within the TNF-α receptor site
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Fig. 4 (See legend on next page.)
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Therefore, the Sitemap® (version 2.3, Schrödinger, LLC,
New York, NY, 2009) module in Maestro Schrödinger®
9.0 version v23118 was utilized to detect the possible po-
tential binding cavities within the receptor. The outcome
of sitemap using OPLS 2005 force field resulted in the
detection of two binding sites [30] and the highest
scored (Table 2) binding site (Figs. 2 and 3) was selected
for the molecular docking.
Statistical analysis
The experimental data were statistically analyzed by the
One-way Analysis of Variance (ANOVA) and expressed
as mean ± S.E.M. followed by Dunnett’s t-test using com-
puterised GraphPad InStat version 3.05, Graph pad
software, USA. The differences are considered significant
when p < 0.05.
Results and discussion
In vivo studies to validate the effect of EE and IC
Effects on carrageenan-induced right paw edema
Carrageenan-induced inflammation model is a well-
established method used for acute inflammation. The
edema expansion follows biphasic responses. The early
phase (within 1 h) is mediated by the discharge of auta-
coids, viz. histamine, kinins and serotonin, while the
later phase (after 1 h) involves prostaglandins; the link
between the two phases is provided by kinins [31]. Oral
administration of EE (100 and 200 mg/kg) exhibited sig-
nificant inhibition of carrageenan-induced inflammation
(Fig. 4a). The EE (100 and 200 mg/kg) exhibited signifi-
cant (p < 0.01) anti-inflammatory activity 3 h after carra-
geenan injection. On other hand, IC (400 and 600 μg/kg)
treatment significantly (p < 0.05–0.01) inhibited carra-
geenan induced paw edema 2 h after carrageenan
administration. The maximum inhibitory values of
oedema at 3 h post-carrageenan were 16.2 and 17.9 %
with the doses of 100 and 200 mg/kg of EE, respect-
ively. However, IC (400 and 600 μg/kg) ensured max-
imum inhibition of 32.0 and 35.2 %, respectively, after
4 h of carrageenan injection. The anti-inflammatory
effects of EE and IC were compared with the standard
drug, aspirin (10 mg/kg), which exhibited significant
inhibition of paw edema 1 h onward post-carrageenan
treatment. Based on this observation, this activity might
be attributed to the inhibition of the release of afore-
mentioned inflammatory mediators.
Effect on arachidonic acid and xylene-induced right ear
oedema
The arachidonic acid and xylene can cause an acute in-
flammatory response and lead to severe vasodilation and
oedematous changes [32]. The results showed that EE
(200 mg/kg) exhibited significant (p < 0.05) suppression
of arachidonic acid and xylene-induced ear oedema in
mice, while the effect of IC (400 and 600 μg/kg) is more
pronounced (p < 0.01) (Fig. 4b). The activity of IC
(600 μg/kg) was found nearly comparable to that of posi-
tive control aspirin (10 mg/kg). Arachidonic acid is a
precursor of PGE-2. Besides, arachidonic acid also can
act as a second messenger to regulate many cellular pro-
cesses including nitric oxide formation [33]. Therefore,
the observed effect may be due to inhibition of PGE-2
and/or NO production. On other hand, xylene causes
the release of pro-inflammatory mediators from sensory
neurons that act on peripheral target cells such as mast
cells and other immune cells producing neurogenic
inflammation [34].
Effect on granuloma tissue formation
The inflammatory granuloma tissue formation is a fea-
ture of chronic inflammation. It evaluates the effects on
macrophage dysfunction and granuloma formation [3].
Macrophage activation during the process of chronic
inflammation causes release of pro-inflammatory media-
tors, including TNF-α, and participates in the subsequent
process of inflammation [35]. Figure 4c depicted that the
effect of EE and IC on granuloma tissue formation. EE
exhibited significant (p < 0.05) inhibition of dry weight of
(See figure on previous page.)
Fig. 4 Effect of EE and IC in acute and chronic inflammations in mice. Panel a: Effect on carrageenan induced paw edema in mice. Panel b: Effect
on xylene and arachidonic acid-induced mouse ear model. Percent of oedema weight = 100 x (WR-WL)/WL; where WR is the mass of right ear, WL
mass left ear. Panel c: Effect on cotton pellet granumola in experimental mice. Values are expressed as mean ± SE (n = 6). *p < 0.05 compared with
control group. **p < 0.01 compared with control group
Fig. 5 Effect of IC in NO, PGE-2 and TNF-α production in PBS stimulated
RAW 264.7 cells. Values are expressed as mean ± SE (n= 3)
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the cotton-pellet granuloma. The inhibitory values for
100, 200 mg/kg of the EE were ~ 30.3 and 33.4 %, re-
spectively. IC exhibited significant (p < 0.01) inhibition
of granuloma tissue formation with inhibition values of
40.2 and 42.1 % for the doses of 400 and 600 μg/kg,
respectively. The effect of IC (600 μg/kg) was found
nearly comparable to that of positive control, the stand-
ard anti-inflammatory agent, aspirin (10 mg/kg), which
exhibited an inhibitory value of ~ 43.3 %. The inhibitory
effect of test materials may be due to inhibition of
macrophage activation. Based on the results of in vivo
studies, IC was further subjected to in vitro experiment
to elucidate its possible mechanism.
In vitro studies to predict the probable mechanism
Effect of IC on NO, PGE-2 and TNF-α production
The effects of IC on LPS stimulated NO, PGE-2 and
TNF-α production in RAW 264.7 cells were depicted in
Fig. 5. LPS-induced macrophage activation increased the
production of pro-inflammatory cytokines and inflam-
matory mediators, including NO, PGE-2 and TNF-α
[36]. IC caused a concentration-dependent inhibition of
LPS-stimulated NO production up to ~ 67.4 % at the
highest used dose of 50 μM. NO plays an important role
in various inflammatory conditions and in tissues is sus-
ceptible to manipulation by pro-inflammatory cytokines
[37]. The inhibition of TNF-α production also follows a
concentration-dependent manner. IC caused a max-
imum inhibition of LPS stimulated TNF-α production
of ~84.5 % at the dose of 50 μM and the steady state
inhibition (>80 %) attained between 1 and 50 μM
Table 3 Pharmacokinetic prediction of selected compound (IC)
by QikProp® 3.2










10 Human oral absorption 3
11 % human oral absorption 77.61
12 #rtvFG 0
13 CNS −2.0
14 Lipinski’s rule of five 0
Fig. 6 3D view of docking pose of minimum energy structure complex of IC docked at the predicted active site of TNF-α (PDB ID: 1A8M) viewed
using Glide XP visualizer of Schrödinger Maestro. Hydrogen bond is shown as yellow dash and bonded with GLN 47
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Fig. 7 Hydrophilic-lipophilic contour (White portion include Hydrophilic domain of TNF-α and brown portion indicate Hydrophobic domain
of TNF-α)
Fig. 8 The key amino acids were shown within the active site of TNF-α after docking
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concentration range. However, the PGE-2 inhibition did
not follow a dose-dependent pattern. The maximum in-
hibition of ~61.4 % was observed between the 1 and
5 μM. Based on in vitro observations, it would be hy-
pothesized that IC possibly acts through inhibition of
TNF-α production. Therefore, molecular docking has
been performed on the basis of interaction with TNF-α.
In silico observations
ADME
The predicted value of Lipinski’s rule of five for IC is
within the range of stipulated values. The predicted values
of each individual parameters necessary for Lipinski’s rule
of five (mol_MW, QPlogPo/w, donorHB and accptHB)
are also well within the recommended range (Table 3)
which indicate that IC has property of drug-likeness [38].
The calculated values of total solvent accessible surface
area (SASA) along with its hydrophobic component
(FOSA), hydrophilic component (FISA), the π component
(PISA) and volume of IC are within the stipulated ranges
which favours the fixation of IC with hydrophilic-
hydrophobic contour of TNF-α receptor. The predicted
qualitative human oral absorption of IC is high (3 in our
case) and the percent of human oral absorption value is
77.61 %, very close to the recommended values. The num-
ber of reactive functional groups that can produce reactiv-
ity and toxicity problems in vivo is zero. Finally, the
predictive central nervous activity of IC is −2, which indi-
cates that IC is CNS inactive.
Active site prediction and molecular docking
In the present assessment of ligand-receptor interac-
tions using Glide, IC showed hydrogen bonding with
GLN 47 amino acid residue (Fig. 6). The G score of
−3.286 obtained by the dock pose of IC complemented
by the hydrophilic-hydrophobic contour of TNF-α pro-
tein (Fig. 7). The hydrogen bond interaction occurred
with oxygen atom of the isolated compounds and GLN
47. The oxygen atom served as hydrogen bond acceptor
with the –NH2 group of glutamine. This also correlates
with the calculated values of accptHB of IC (5.5 in our
case). Molecular docking study also reveals the best
possible environment necessary for drug receptor inter-
action. The hydrophilic-hydrophobic domain of the
predicted active site of TNF-α comprises of ARG 131,
ASP 45, LYS 90, GLN 47, ASN 46, GLU 135, GLN 27,
GLN 25, LEU 26, GLU 23 and GLY 24 amino acid resi-
dues (Fig. 8). The similar types of molecular docking
were reported earlier to understand the probable inter-
actions between TNF-α protein and IC [39, 40].
Conclusion
In the present study, we found that the root bark of Z.
nummularia exhibited significant anti-inflammatory
activity. We also observed that, octadecahydro-picene-
2,3,14,15-tetranone isolated from the root bark of Z.
nummularia exhibited significant anti-inflammatory ac-
tivity. To predict the mechanism, in vitro assays were
performed to see the effect of IC on LPS stimulated
NO, PGE-2 and TNF-α production in RAW 264.7 cells.
Among the tested mediators, IC significantly inhibited
LPS stimulated TNF-α and NO production. However,
the inhibitory effect on TNF-α production has been
found more pronounced. Based on quantitative value/
inhibition characteristics, molecular docking studies
were performed on TNF-α protein. Molecular docking
study further helped in supporting the observed TNF-α
selectivity. Based on these observation, IC can be
regarded as an anti-inflammatory agent with possible
inhibitory effect on NO and TNF-α production. There-
fore, the compound may have clinical potential for the
treatment of inflammation in future.
Additional file
Additional file 1: Figure S1. The effect of octadecahydro-picene-
2,3,14,15-tetranone on the viability of RAW 264.7 cells. (PPTX 47 kb)
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